Capricor Therapeutics (4LN2.STU) Q2 2026 Earnings

12MayConfirmed
Q1 2026
Q2 2026
-0.54
-0.5
-0.47
-0.43

Details

Expected EPS
-0.432384925
Actual EPS
-0.5026741
Surprise EPS
-0.07
Surprise Percent
+16.26%

Description

Capricor Therapeutics (4LN2.STU) has reported earnings of -0.5026741 per share for Q2 2026.

0 Comments

Share your thoughts